MorphoSys Accounts Payable vs Total Current Liabilities Analysis

MOR Stock  USD 18.17  0.03  0.17%   
MorphoSys financial indicator trend analysis is infinitely more than just investigating MorphoSys AG ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MorphoSys AG ADR is a good investment. Please check the relationship between MorphoSys Accounts Payable and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MorphoSys AG ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Accounts Payable vs Total Current Liabilities

Accounts Payable vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MorphoSys AG ADR Accounts Payable account and Total Current Liabilities. At this time, the significance of the direction appears to have strong relationship.
The correlation between MorphoSys' Accounts Payable and Total Current Liabilities is 0.79. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of MorphoSys AG ADR, assuming nothing else is changed. The correlation between historical values of MorphoSys' Accounts Payable and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of MorphoSys AG ADR are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Accounts Payable i.e., MorphoSys' Accounts Payable and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.79
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents MorphoSys obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of MorphoSys AG ADR are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Current Liabilities

Total Current Liabilities is an item on MorphoSys balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of MorphoSys AG ADR are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from MorphoSys' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MorphoSys AG ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MorphoSys AG ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
At this time, MorphoSys' Selling General Administrative is relatively stable compared to the past year. As of 06/06/2024, Sales General And Administrative To Revenue is likely to grow to 0.38, though Tax Provision is likely to grow to (1.1 M).
 2021 2022 2023 2024 (projected)
Interest Expense181.5M116.5M109.9M115.4M
Depreciation And Amortization98.4M10.5M10.5M10.4M

MorphoSys fundamental ratios Correlations

0.980.99-0.240.820.7-0.890.820.760.97-0.030.930.710.660.98-0.230.90.980.950.940.920.750.590.090.760.88
0.980.99-0.360.780.75-0.920.770.760.970.040.90.640.570.98-0.20.870.980.940.890.930.670.51-0.030.820.92
0.990.99-0.30.780.76-0.920.790.740.97-0.010.920.70.630.98-0.220.90.990.930.920.930.730.540.040.820.92
-0.24-0.36-0.30.08-0.40.530.0-0.26-0.430.150.050.210.35-0.42-0.12-0.06-0.41-0.170.05-0.550.180.240.32-0.58-0.43
0.820.780.780.080.32-0.520.910.670.7-0.010.90.450.580.75-0.060.620.750.930.90.590.50.770.10.30.53
0.70.750.76-0.40.32-0.790.440.250.72-0.10.610.550.330.72-0.160.730.730.540.60.70.550.34-0.170.910.92
-0.89-0.92-0.920.53-0.52-0.79-0.57-0.7-0.95-0.07-0.72-0.67-0.54-0.930.24-0.88-0.93-0.78-0.72-0.96-0.69-0.250.09-0.92-0.93
0.820.770.790.00.910.44-0.570.490.750.020.850.490.580.770.10.640.770.890.840.630.530.87-0.030.370.56
0.760.760.74-0.260.670.25-0.70.490.750.00.660.530.550.76-0.210.640.760.760.70.760.570.120.220.530.6
0.970.970.97-0.430.70.72-0.950.750.75-0.020.830.650.570.99-0.20.860.990.890.840.980.690.470.020.830.89
-0.030.04-0.010.15-0.01-0.1-0.070.020.0-0.020.00.20.27-0.06-0.150.18-0.060.13-0.05-0.060.2-0.07-0.23-0.12-0.08
0.930.90.920.050.90.61-0.720.850.660.830.00.70.710.86-0.240.860.870.930.990.720.730.710.070.580.77
0.710.640.70.210.450.55-0.670.490.530.650.20.70.940.62-0.350.90.630.590.720.61.00.30.220.590.66
0.660.570.630.350.580.33-0.540.580.550.570.270.710.940.55-0.290.80.560.630.730.50.940.410.220.370.49
0.980.980.98-0.420.750.72-0.930.770.760.99-0.060.860.620.55-0.190.841.00.920.870.970.660.510.030.820.9
-0.23-0.2-0.22-0.12-0.06-0.160.240.1-0.21-0.2-0.15-0.24-0.35-0.29-0.19-0.35-0.19-0.15-0.25-0.2-0.340.02-0.37-0.18-0.22
0.90.870.9-0.060.620.73-0.880.640.640.860.180.860.90.80.84-0.350.850.80.850.810.910.420.050.770.86
0.980.980.99-0.410.750.73-0.930.770.760.99-0.060.870.630.561.0-0.190.850.920.880.970.670.510.030.820.9
0.950.940.93-0.170.930.54-0.780.890.760.890.130.930.590.630.92-0.150.80.920.930.820.630.660.030.580.75
0.940.890.920.050.90.6-0.720.840.70.84-0.050.990.720.730.87-0.250.850.880.930.740.750.690.190.590.77
0.920.930.93-0.550.590.7-0.960.630.760.98-0.060.720.60.50.97-0.20.810.970.820.740.640.330.020.860.88
0.750.670.730.180.50.55-0.690.530.570.690.20.731.00.940.66-0.340.910.670.630.750.640.330.230.60.68
0.590.510.540.240.770.34-0.250.870.120.47-0.070.710.30.410.510.020.420.510.660.690.330.330.060.120.32
0.09-0.030.040.320.1-0.170.09-0.030.220.02-0.230.070.220.220.03-0.370.050.030.030.190.020.230.06-0.08-0.06
0.760.820.82-0.580.30.91-0.920.370.530.83-0.120.580.590.370.82-0.180.770.820.580.590.860.60.12-0.080.96
0.880.920.92-0.430.530.92-0.930.560.60.89-0.080.770.660.490.9-0.220.860.90.750.770.880.680.32-0.060.96
Click cells to compare fundamentals

MorphoSys Account Relationship Matchups

MorphoSys fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets496.4M1.7B2.6B2.4B2.0B2.1B
Other Current Liab46.8M146.9M206.9M230.2M202.4M212.5M
Total Current Liabilities61.6M200.5M284.5M278.3M264.3M277.5M
Total Stockholder Equity394.7M621.3M244.9M157.4M49.0M46.6M
Property Plant And Equipment Net4.7M50.7M49.6M51.0M15.0M11.8M
Net Debt(1.7M)208.4M202.5M(62.9M)477.4M501.3M
Retained Earnings(255.8M)(157.9M)(672.3M)(823.4M)(1.0B)(962.5M)
Accounts Payable10.7M47.6M73.8M38.6M28.4M14.7M
Cash44.3M109.8M123.2M402.4M158.5M166.4M
Non Current Assets Total192.7M452.7M1.4B1.3B1.2B1.3B
Non Currrent Assets Other44.1M1.6M4.1M8.7M1.2M1.2M
Cash And Short Term Investments272.5M1.1B993.7M907.2M682.8M716.9M
Common Stock Total Equity29.4M31.8M32.0M32.9M37.8M34.8M
Common Stock Shares Outstanding126.4M132.7M133.6M136.6M137.3M108.5M
Liabilities And Stockholders Equity496.4M1.7B2.6B2.4B2.0B2.1B
Non Current Liabilities Total40.2M837.7M2.0B2.0B1.7B1.8B
Other Current Assets(40.3K)10.0M15.9M(367.0)24.022.8
Other Stockholder Equity619.8M744.1M830.2M831.3M936.1M982.9M
Total Liab101.7M1.0B2.3B2.2B2.0B2.1B
Property Plant And Equipment Gross20.8M50.7M69.9M71.5M37.7M39.6M
Total Current Assets303.7M1.2B1.1B1.1B814.0M854.7M
Intangible Assets41.1M69.4M838.3M886.6M844.1M886.3M
Common Stock31.8M32.0M32.9M34.2M37.7M35.4M
Other Assets1.1M134.4M199.8M8.7M10.0M9.5M
Net Receivables20.3M89.8M85.8M112.4M42.7M83.8M
Inventory288.2K10.0M20.8M24.3M62.1M65.2M
Short Long Term Debt Total42.6M318.2M325.8M339.5M635.9M667.7M
Good Will3.7M1.6M335.6M356.2M342.3M359.4M
Accumulated Other Comprehensive Income(1.3M)2.2M52.8M115.3M88.4M92.9M
Current Deferred Revenue1.6M2.5M223.9K19.4M17.5M18.4M
Short Term Investments228.2M980.5M870.4M504.8M524.3M372.9M
Short Term Debt2.5M3.5M3.7M9.6M14.1M14.2M
Other Liab138.1K523.0M1.7B1.6B1.9B2.0B
Net Tangible Assets349.9M550.3M(929.0M)(1.1B)(976.9M)(928.0M)
Long Term Debt0.0272.8M282.8M291.6M613.1M643.7M
Long Term Investments96.0M99.0M196.6M5.4M3.6M3.4M
Property Plant Equipment47.8M50.7M49.6M51.0M58.6M61.6M
Capital Lease Obligations42.6M45.0M42.6M45.8M12.4M23.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Tools for MorphoSys Stock Analysis

When running MorphoSys' price analysis, check to measure MorphoSys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MorphoSys is operating at the current time. Most of MorphoSys' value examination focuses on studying past and present price action to predict the probability of MorphoSys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MorphoSys' price. Additionally, you may evaluate how the addition of MorphoSys to your portfolios can decrease your overall portfolio volatility.